BioSpace News Archive

Autobahn Therapeutics, a biotechnology company focused on restoring hope for people affected by CNS disorders, today announced the appointment of Scott Forrest, Ph.D., to the company’s newly created position of chief business officer. In this role, Dr. Forrest will oversee corporate development, portfolio strategic planning and financial strategy, and will report to Kevin Finney, chief executive officer. “Scott is a seaso

Varex Imaging Corporation (Nasdaq: VREX) today announced that it will showcase its latest X-ray tubes and sources, digital detectors, connect and control devices, and software solutions at the 32 nd annual European Congress of Radiology (ECR). The European Society of Radiology’s 2020 congress has transitioned to a virtual exhibition format, which will take place July 15 - 21, 2020. In addition to Varex’s existing X-

KAHTNU Surgical, a U.S. medical technology company based in Alaska, announced today it had completed a $2.15 million Series A round of financing led by Kinetic Medical Co., Ltd.

7D Surgical announced today that it has achieved CE Mark certification for its innovative Machine-vision Image Guided Surgery (MvIGS) system for spine surgery. This achievement clears the way for 7D Surgical to commence commercialization efforts of its spinal platform across the European market and additional global regions. The 7D Surgi

Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced the publication of a multicenter, prospective study demonstrating that DecisionDx ® -UM test results significantly impacted treatment plan recommendations for patients with uveal me

Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced that the FDA provided positive feedback during the company’s End of Phase 2 (EOP2) meeting for Oramed’s oral insulin (ORMD-0801)

The Only Computer Vision Testing Device to Combine Standardized Contrast Sensitivity Testing with a Full Suite of Clinical Vision Tests

Vivera Pharmaceuticals, Inc. is pleased to announce the appointment of Tony Sanchez, Jr. to its Advisory Board. The Former President of The Seminole Tribe of Florida , Inc. and Vice-Chairman, Seminole Tribe of Florida will advise on Vivera’s growing involvement in tribal healthcare initiatives.

The Solve ME/CFS Initiative (Solve M.E.) today announced the official launch of the You + M.E. Registry and Biobank, a resource of clinical information, patient-reported symptoms, and bio samples that can be used by researchers to better understand Myalgic Encephalomyelitis (ME), also known as Chronic Fatigue Syndrome (CFS) or ME/CFS.

Company’s proprietary pharmacy technology and micro-fulfilment strategy dramatically increase speed of prescription delivery, reduce costs and improve consumer experience